Investing
The company, spun out of MIT and backed by Define Ventures, GV and Flare Capital Partners, was founded by veteran AI and clinical leaders from MIT, Harvard, Microsoft and Google.
The company says it partnered with child psychologists to develop an online safety platform for individuals and families to protect children from "technology's negative effects."
The company will use the funds to invest in technology and expand into new market segments.
The company will use the funds to expand its presence across the U.S. health market and enhance its AI technology and platform.
Its digital marketplace, featuring over a million products, seeks to address issues in the global procurement of critical healthcare equipment.
Also, two Korean digital dentistry solutions providers are integrating AI into their dental diagnostic software.
The company will use the funds to accelerate commercial expansion of its ANNE One medical wearable in the United States and Europe.
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.